nChroma Bio
6 known investors
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
BiotechDeep TechMedical Devices
Founders & leadership
LG
Luke Gilbert, PhD
KJ
Keith Joung, MD, PhD
DL
David Liu, PhD
AL
Angelo Lombardo, PhD
LN
Luigi Naldini, MD, PhD
JW
Jonathan Weissman, PhD
Investors · 6
In the news
- nChroma Bio Raises $75M to Advance Epigenetic Editing for Hepatitis B and D Cure | Contagion Livecontagionlive.com · 2026
- nChroma Bio Inc - MassBiomassbio.org · 2026
- nChroma Bio: $75 Million Raised To Advance Genetic Medicinespulse2.com · 2024
- Chroma Medicine, Nvelop Therapeutics Merge as nChroma Bio with Focus on Epigenetic Therapiesgenengnews.com · 2024
- Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio and Raises $75Mfinsmes.com · 2024
- 2 Boston-area biotechs shed staff, fuse to form genetic medicines company nChroma Biofiercebiotech.com · 2024